Sialorrhea - Pipeline Insight, 2019

06/nov/2019 05:58:37 Vidhyanigam98 Contatta l'autore

Questo comunicato è stato pubblicato più di 6 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Bharat Book Bureau Provides the Trending Market Research Report on "Sialorrhea - Pipeline Insight, 2019"  under  Pharmaceutical  category. The report offers a collection of market research, market analysis, competitive intelligence and industry reports.

Sialorrhea- Pipeline Insight, 2019 report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the indication. A detailed picture of the  Sialorrhea pipeline landscape is provided which includes the disease overview and Sialorrhea treatment guidelines. The assessment of the report embraces, in depth Sialorrhea commercial assessment and clinical assessment of the pipeline products under development. In the report, a detailed description of the drug, clinical studies, NDA approvals (if any), and product development activities including technology, licensing, mergers and acquisition, funding, designations and other product related details.

Sialorrhea Understanding

Sialorrhea (drooling or excessive salivation) is a common problem in neurologically impaired children (ie, those with mental retardation or cerebral palsy) and adults who have Parkinson's disease or have had a stroke. It is most commonly caused by poor oral and facial muscle control. Contributing factors may include hypersecretion of saliva, dental malocclusion, postural problems, and inability to recognize salivary spill. Sialorrhea causes a range of physical and psychosocial complications, including perioral chapping, dehydration, odor, and social stigmatization that can be devastating to patients and their families. Sialorrhea (drooling or excessive salivation) is defined as saliva beyond the margin of the lip. This condition is normal in infants but usually stops by 15 to 18 months of age.

Request a free sample copy of Sialorrhea Report @

Sialorrhea Pipeline Development Activities

The report provides insights into different therapeutic candidates in discovery and preclinical, phase 1, phase 2, and phase 3 stages. Drugs under development as monotherapy or combination therapy are also included. It also analyzes key players involved in the targeted targeted therapeutics with their active and inactive (dormant or discontinued) projects with the appropriate reasons if available. Sialorrhea pipeline report covers 4+ companies. Some of the key players include Neos Therapeutics (NT 0501) etc.

The report is built using data and information from the researcher's proprietary databases, company / university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company / university web sites and industry-specific third party sources, etc .

Sialorrhea Analytical Perspective by DelveInsight

• In-depth Sialorrhea Commercial Assessment of products
This report provides an in-depth Commercial Assessment of therapeutic drugs which is included of collaborations, Licensing, Acquisition –Deal Value Trends. The sub-segmentation is described in the report which includes Company-Company Collaborations (Licensing / Partnering), Company-Academia Collaborations, and Acquisition analysis in both Graphical and tabulated form.

• Sialorrhea Clinical Assessment of products
The report comprises of comparative clinical assessments of products by development stage, product type, route of administration, molecule type, and MOA type across this indication.

Scope of the report

• The sialorrhea report Provides an overview of therapeutic pipeline activity for sialorrhea across the complete product development cycle including all clinical and non-clinical stages
• It comprises of detailed profiles of sialorrhea therapeutic products with key coverage of developmental activities including technology, collaborations, licensing, mergers and acquisitions, funding, designations and other product related details
• Detailed sialorrhea Research and Development progress and trial details, results wherever available, are Also included in the pipeline study
• Therapeutic assessment of the active pipeline products by development stages, product type, route of administration, molecule type, and MOA type
• Coverage of dormant and discontinued pipeline projects with the reasons if available across Sialorrhea

Reasons to Buy

• Establish a comprehensive understanding of the current pipeline scenario
Sialorrhea R&D
• Develop strategic initiatives by understanding the focus areas of leading companies.
Devise Sialorrhea is under license and create effective counter strategies to gain competitive advantage
• Get in detail
on licensing and out licensing strategies by identifying prospective partners with progressing projects for sialorrhea to Enhance and expand business potential and scope
• Our extensive domain knowledge on therapy areas support the clients in the decision-making process Regarding Their therapeutic portfolio by identifying the reason behind the inactive or discontinued drugs

Browse our full report with Table of Content:

About Bharat Book Bureau:
Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 4,80,000 reports and insights that includes latest Market Study, Market Trends & Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall coverage of major industries with a further segmentation of 100+ subsectors.

Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772/27810773

Follow us on:  Twitter Facebook LinkedIn

blog comments powered by Disqus è un servizio offerto da Factotum Srl